Healthcare provider profile · identity verified

Elizabeth Solano, M.D.

Internal Medicine · KENSINGTON, CT · NPI 1275544157

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Tramadol Hcl	Tramadol Hcl	534	87
Rosuvastatin Calcium	Rosuvastatin Calcium	490	142
Atorvastatin Calcium	Atorvastatin Calcium	459	144
Lisinopril	Lisinopril	435	122
Levothyroxine Sodium	Levothyroxine Sodium	363	91
Omeprazole	Omeprazole	214	59
Amlodipine Besylate	Amlodipine Besylate	212	70
Montelukast Sodium	Montelukast Sodium	199	52
Ozempic	Semaglutide	176	29
Gabapentin	Gabapentin	156	45
Sertraline Hcl	Sertraline Hcl	155	50
Pantoprazole Sodium	Pantoprazole Sodium	153	53
Januvia	Sitagliptin Phosphate	152	36
Metformin Hcl Er	Metformin Hcl	149	45
Albuterol Sulfate Hfa	Albuterol Sulfate	144	59
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	137	50
Losartan Potassium	Losartan Potassium	133	39
Escitalopram Oxalate	Escitalopram Oxalate	132	49
Alendronate Sodium	Alendronate Sodium	128	36
Fluticasone Propionate	Fluticasone Propionate	128	50
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	122	26
Carvedilol	Carvedilol	121	27
Hydrochlorothiazide	Hydrochlorothiazide	111	33
Metformin Hcl	Metformin Hcl	110	34
Donepezil Hcl	Donepezil Hcl	108	29
Furosemide	Furosemide	105	29
Mirtazapine	Mirtazapine	96	25
Breo Ellipta	Fluticasone/Vilanterol	91	24
Trulicity	Dulaglutide	91	17
Ibuprofen	Ibuprofen	90	34
Zolpidem Tartrate	Zolpidem Tartrate	86	15
Memantine Hcl Er	Memantine Hcl	85	25
Metoprolol Succinate	Metoprolol Succinate	78	26
Pravastatin Sodium	Pravastatin Sodium	76	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	21
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	69	21
Buspirone Hcl	Buspirone Hcl	67	23
Jardiance	Empagliflozin	66	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	65	14
Trazodone Hcl	Trazodone Hcl	62	18
Citalopram Hbr	Citalopram Hydrobromide	61	17
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	60	suppressed
Allopurinol	Allopurinol	57	14
Clonazepam	Clonazepam	57	11
Symbicort	Budesonide/Formoterol Fumarate	57	22
Ezetimibe	Ezetimibe	56	20
Tamsulosin Hcl	Tamsulosin Hcl	55	20
Eliquis	Apixaban	53	11
Benazepril Hcl	Benazepril Hcl	52	13
Esomeprazole Magnesium	Esomeprazole Magnesium	51	18
Memantine Hcl	Memantine Hcl	51	18
Metoprolol Tartrate	Metoprolol Tartrate	51	18
Tradjenta	Linagliptin	51	15
Olmesartan Medoxomil	Olmesartan Medoxomil	49	18
Simvastatin	Simvastatin	45	13
Alprazolam	Alprazolam	43	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	42	13
Tizanidine Hcl	Tizanidine Hcl	42	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Vascepa	Icosapent Ethyl	41	17
Meclizine Hcl	Meclizine Hcl	40	15
Synthroid	Levothyroxine Sodium	40	14
Bupropion Hcl Sr	Bupropion Hcl	38	15
Diclofenac Sodium	Diclofenac Sodium	38	12
Duloxetine Hcl	Duloxetine Hcl	38	12
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Azithromycin	Azithromycin	36	30
Fenofibrate	Fenofibrate Nanocrystallized	36	13
Repaglinide	Repaglinide	35	suppressed
Famotidine	Famotidine	34	16
Meloxicam	Meloxicam	34	13
Acetaminophen-Codeine	Acetaminophen With Codeine	33	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	27
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Atenolol	Atenolol	31	suppressed
Clotrimazole	Clotrimazole	31	15
Tresiba Flextouch U-200	Insulin Degludec	31	suppressed
Trintellix	Vortioxetine Hydrobromide	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Topiramate	Topiramate	26	suppressed
Lorazepam	Lorazepam	25	12
Pregabalin	Pregabalin	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	11
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Dexlansoprazole Dr	Dexlansoprazole	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Glipizide	Glipizide	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	20	suppressed
Methylprednisolone	Methylprednisolone	20	17
Naproxen	Naproxen	20	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	11
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Prednisone	Prednisone	16	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	15	suppressed
Fluconazole	Fluconazole	14	suppressed
Humalog	Insulin Lispro	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Byetta	Exenatide	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nystatin	Nystatin	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error